Similar articles

• Prospective audit of the introduction of insulin glargine (lantus) into clinical practice in type 1 diabetic patients.

  Gallen IW, Carter C. Gallen IW, et al. Diabetes Care. 2003 Dec;26(12):3352-3. doi: 10.2337/diacare.26.12.3352. Diabetes Care. 2003. PMID: 14633830 No abstract available.
• FreeStyle navigator continuous glucose monitoring system use in children with type 1 diabetes using glargine-based multiple daily dose regimens: results of a pilot trial Diabetes Research in Children Network (DirecNet) Study Group.

  Weinzimer S, Xing D, Tansey M, Fiallo-Scharer R, Mauras N, Wysocki T, Beck R, Tamborlane W, Ruedy K; Diabetes Research in Children Network (DirecNet) Study Group. Weinzimer S, et al. Diabetes Care. 2008 Mar;31(3):525-7. doi: 10.2337/dc07-1995. Epub 2007 Dec 20. Diabetes Care. 2008. PMID: 18096811 Free PMC article.
• Efficacy of conversion from bedtime NPH insulin injection to once- or twice-daily injections of insulin glargine in type 1 diabetic patients using basal/bolus therapy.

  Albright ES, Desmond R, Bell DS. Albright ES, et al. Diabetes Care. 2004 Feb;27(2):632-3. doi: 10.2337/diacare.27.2.632. Diabetes Care. 2004. PMID: 14747268 Clinical Trial. No abstract available.
• Insulin glargine clinical trials.

  White JR Jr. White JR Jr. Clin Ther. 2004 Jul;26(7):1179-81; discussion 1182-3. doi: 10.1016/s0149-2918(04)90190-7. Clin Ther. 2004. PMID: 15336483 Review. No abstract available.
• [Long acting insulin analogs: possibly more stable glucose regulation].

  Huvers F. Huvers F. Ned Tijdschr Geneeskd. 2004 Aug 21;148(34):1674-8. Ned Tijdschr Geneeskd. 2004. PMID: 15453119 Review. Dutch.